← Browse by Condition
Medical Condition
stage iv lung cancer ajcc v8
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 1
NCT06122064
Recruiting
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
NCT03582124 Phase 1, Phase 2
Recruiting
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Enrollment
30 pts
Location
United States
Sponsor
Stanford University
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04762199 Phase 1
Recruiting
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
Enrollment
69 pts
Location
United States
Sponsor
Emory University
NCT05493566 EARLY_Phase 1
Recruiting
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Enrollment
15 pts
Location
United States
Sponsor
Emory University